ADVB

Advanced Biomed Inc. Common Stock
ADVB
Market cap $20.8M

0.9599 USD

+0.0018

0.19%

At close Jun 13, 4:00 PM EDT

After hours

0.9550

-0.0049

0.51%

1 day

0.19%

5 days

-2.10%

1 month

-5.89%

3 months

-72.81%

6 months

-73.70%

Year to date

-73.70%

1 year

-73.70%

5 years

-73.70%

10 years

-73.70%

About: Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Healthcare Diagnostics & Research

0

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.05% more ownership

Funds ownership: 0% [Q4 2024] → 0.05% (+0.05%) [Q1 2025]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ADVB.

See Analyst Rankings

Financial journalist opinion

Sonoro Energy, Advanced BioCatalytics, and NexTier Energy Launch Strategic Collaboration to Advance Heavy Oil Recovery from Carbonate Reservoirs in the Middle East

May 5, 2025 – TheNewswire - Calgary, Alberta – Sonoro Energy Ltd. (“Sonoro” or the “Company” (TSX Venture: SNV) is pleased to announce that Sonoro, Advanced BioCatalytics Corporation, and NexTier Energy LLC have developed a strategic collaboration focused on enhancing heavy oil production from carbonate reservoirs in the Middle East through the application of cutting-edge enhanced oil recovery (EOR) technologies. The partnership leverages the complementary strengths of each company—biotechnology innovation, reservoir engineering expertise, and regional energy leadership—to address one of the more technically challenging resource opportunities in the global energy sector

Sonoro Energy, Advanced BioCatalytics, and NexTier Energy Launch Strategic Collaboration to Advance Heavy Oil Recovery from Carbonate Reservoirs in the Middle East

Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of its initial public offering (the "Offering") of 1,640,000 shares of common stock (the “Shares”), at a public offering price of $4.00 per share for total gross proceeds of $6.56 million before deducting underwriting discounts and offering expenses. The Shares began trading on the Nasdaq Capital Market on March 6, 2025 under the ticker symbol “ADVB.”

Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

See News Rankings

Charts implemented using Lightweight Charts™